Reapplix has established that one of the keys to successful wound treatment lies in the body’s capacity to heal – and each patient is central to that process. Founded in 2008, Reapplix specializes in the biological treatment and management of diabetic foot ulcers. The patented 3CPatch® System is an innovative, evidence-based biological wound therapy made entirely from the patient’s own blood – nothing else. Headquartered in Denmark, with sales and distribution teams in the US and Europe, Reapplix won the 2018 EY Entrepreneur of the Year Award in the life science category.
The Clinical Director is a strategic clinical leader responsible for establishing 3C Patch as a category-defining therapy in wound care. Key priorities include developing and delivering clinical education programs, driving real-world evidence generation, and building and managing Key Opinion Leader (KOL) relationships. This role requires expertise in wound care, leadership skills, and the ability to translate clinical insights into strategic impact.
Minimum Requirements
Job Requirements